Developing new drugs for Alzheimer's and related dementias
Leadership in AD/ADRD Drug Discovery
This study is all about finding new treatments for Alzheimer's and similar conditions, and it aims to help new scientists learn and work together to discover better ways to fight these diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10898046 on NIH RePORTER |
What this research studies
This research focuses on creating a robust infrastructure for drug discovery aimed at Alzheimer's disease and related dementias. The project will involve mentoring new researchers and leveraging the extensive resources at Scripps Research to identify novel therapeutic agents. The goal is to inspire and build a collaborative environment that fosters innovation in drug development, particularly targeting disease-modifying therapies. The research will also contribute to training the next generation of scientists in this critical field.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias who are seeking new treatment options.
Not a fit: Patients with non-Alzheimer's related cognitive impairments or those who do not have a diagnosis of dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments that modify the progression of Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown success in developing FDA-approved medications for Alzheimer's, indicating that innovative approaches in this area can yield positive results.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Lipton, Stuart a — Scripps Research Institute, the
- Study coordinator: Lipton, Stuart a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.